Request Demo
Last update 14 Feb 2026
MBS-301
Last update 14 Feb 2026
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms MBS 301, MBS301 |
Target |
Action antagonists |
Mechanism HER2 antagonists(Receptor tyrosine-protein kinase erbB-2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 7414CDR2-L
Sequence Code 8863CDR2-L
Sequence Code 15599CDR3-L
Sequence Code 18476CDR3-L
Sequence Code 18492L
Sequence Code 148702CDR1-H
Sequence Code 9129376CDR3-H
Sequence Code 9129393CDR1-L
Sequence Code 9892301CDR1-L
Sequence Code 9892501CDR3-H
Sequence Code 9892525CDR2-H
Sequence Code 9893011CDR1-H
Sequence Code 1038074938H
Sequence Code 1038074939CDR2-H
Sequence Code 1038074940L
Sequence Code 1038074941H
Related
1
Clinical Trials associated with MBS-301NCT03842085
Evaluation on Open-Labeled and Dose-Escalation Phase I Clinical Study of Safety and Pharmacokinetics of Recombinant Humanized Bispecific Monoclonal Antibody MBS301 for Injection in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor
100 Clinical Results associated with MBS-301
Login to view more data
100 Translational Medicine associated with MBS-301
Login to view more data
100 Patents (Medical) associated with MBS-301
Login to view more data
100 Deals associated with MBS-301
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HER2 Positive Breast Cancer | Phase 1 | China | 14 May 2019 | |
| HER2-positive gastric cancer | Phase 1 | China | 14 May 2019 | |
| HER2 Positive Solid Tumors | Phase 1 | China | 11 Apr 2019 | |
| Metastatic Solid Tumor | Phase 1 | China | 11 Apr 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free